Wei Chen

Dr. Wei Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
WCWei Chen
Wei Chen
ZWZhigang Wang
Zhigang Wang
GYGengfan Ye
Gengfan Ye
GZGuangyao Zhu
Guangyao Zhu
SLShiwei Li
Shiwei Li
MCMao-song Chen
Mao-song Chen
Background: Traumatic brain injury (TBI) remains a major concern for global health. Recent studies have suggested the role of NOD‐like receptor pyrin domain‐containing protein 3 (NLRP3), an inflammatory marker, in the cerebrospinal fluid (CSF) and serum as potential indicators of TBI prognosis. The objective of the study was to characterize NLRP3 as a clinically applicable tool for predicting the outcomes of TBI patients.Methods: A total of 270 patients with moderate to severe TBI were included in this retrospective analysis. Serum and CSF samples were collected at 1‐, 3‐, 7‐, and 21‐day post‐injury to measure NLRP3 levels. The prognosis of patients was evaluated after 3 months using the Glasgow Outcome Scale (GOS). Patients were categorized into good prognosis (GOS score >3) and poor prognosis (GOS score ≤3) groups. The relationship between NLRP3 levels and prognosis was analyzed.Results: Patients with poor prognosis had significantly elevated NLRP3 levels in their serum on days 1 and 3 post‐injury compared with those with a good prognosis. The difference was more pronounced during these early days compared with days 7 and 21. However, NLRP3 levels in CSF consistently showed a large difference between the two groups throughout the observation period. Receiver operating characteristic analysis revealed that the level of NLRP3 in the CSF on day 3 post‐injury had the highest predictive value for prognosis, with an area under the curve of 0.83, followed by the level of NLRP3 in the serum on day 3 post‐injury.Conclusions: The levels of NLRP3, especially in the CSF on day 3 post‐injury, can serve as a potential biomarker for predicting prognosis in moderate to severe TBI patients. Early measurement of NLRP3 levels can provide valuable insights into patient outcomes and guide therapeutic strategies.

14 August 2025 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
YLYalun Li
Yalun Li
WCWei Chen
Wei Chen
JFJiugeng Feng
Jiugeng Feng

16 December 2025 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
PCPan‐Di Chen
Pan‐Di Chen
TSTao‐Tao Shi
Tao‐Tao Shi
DHDan‐Yang Hu
Dan‐Yang Hu
XSXiao‐Na Su
Xiao‐Na Su
JJJian‐Xiang Jin
Jian‐Xiang Jin
WCWei Chen
Wei Chen
Intracerebral hemorrhage (ICH) is a life‐threatening stroke subtype that lacks effective drug therapy. In the context of ICH, neuroinflammation, and ferroptosis are key contributors to secondary brain injury. In this study, we assessed the neuroprotective effects of matrine (MAT) and its mechanism of action involving the HMGB1/RAGE axis in an ICH mouse model. ICH was induced in mice by autologous blood injection. MAT (1.5 or 20 mg/kg) was administered orally 5 min postinduction. ICH significantly upregulated RAGE and its associated proteins (HMGB1, protein kinase C [PKC], phospholipase C [PLC], and β‐amyloid), confirming pathway activation. Molecular docking revealed a specific hydrogen bond interaction between MAT and RAGE but not with PKC or PLC. MAT improved neurological performance, reduced hematoma volume and brain edema, and restored blood–brain barrier integrity through upregulation of tight junction proteins (ZO‐1, Occludin, Claudin‐4). MAT suppressed activation of the HMGB1/RAGE pathway and downstream kinases JNK, p38, ERK1/2, and NF‐κB p65. It also decreased IL‐1β, IL‐6, and TNF‐α levels, reduced Bax, increased Bcl‐2, and mitigated neuronal apoptosis. Additionally, MAT lowered Fe 2+ accumulation, inhibited ACSL4, and restored GPX4 levels, indicating ferroptosis suppression. RAGE knockdown mimicked the effects of MAT and negated its therapeutic benefits. MAT induced no detectable liver or kidney toxicity. This study is the first to demonstrate that MAT alleviates ICH‐induced neurological deficits by targeting the HMGB1/RAGE axis‐mediated ferroptosis, thereby extending the current understanding of the neuroprotective mechanisms of MAT beyond its known anti‐inflammatory and antioxidant actions.

14 September 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
WCWei Chen
Wei Chen
YQYaxin Qin
Yaxin Qin
ZWZhigang Wang
Zhigang Wang
PCPandi Chen
Pandi Chen
GZGuangyao Zhu
Guangyao Zhu
GYGeng-fan Ye
Geng-fan Ye

28 November 2024 in Neuroscience
Verified
Journal Article
Closed access
GYGengfan Ye
Gengfan Ye
ZWZhigang Wang
Zhigang Wang
PCPandi Chen
Pandi Chen
JYJunyi Ye
Junyi Ye
SLShiwei Li
Shiwei Li
WCWei Chen
Wei Chen

1 April 2024 in Journal of Neurophysiology
Verified
Journal Article
Closed access
MCMaosong Chen
Maosong Chen
HWHongcai Wang
Hongcai Wang
PCPandi Chen
Pandi Chen
GZGuangyao Zhu
Guangyao Zhu
SLShiwei Li
Shiwei Li
WCWei Chen
Wei Chen
The study demonstrated that neonatal microglia transplantation within 1 h significantly inhibited the pathogenesis of traumatic brain injury (TBI) in mouse models through inhibition of M1 polarization and promotion of M2 polarization.